Dieter Schwarz
Institute of Clinical Pharmacology
University Medical Center Charité
Humboldt University of Berlin
Schumannstr. 20/21
Germany
Name/email consistency: high
- CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. Schwarz, D., Kisselev, P., Roots, I. Eur. J. Cancer (2005)
- Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns. Schwarz, D., Kisselev, P., Chernogolov, A., Schunck, W.H., Roots, I. Biochem. Biophys. Res. Commun. (2005)
- Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Schwarz, D., Kisselev, P., Ericksen, S.S., Szklarz, G.D., Chernogolov, A., Honeck, H., Schunck, W.H., Roots, I. Biochem. Pharmacol. (2004)
- In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1. Schwarz, D., Roots, I. Biochem. Biophys. Res. Commun. (2003)
- St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1. Schwarz, D., Kisselev, P., Roots, I. Cancer Res. (2003)









